Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aaron Bress

Diagnostic Radiology Murray, UT Doctor of Osteopathy

NPI 1770712879 CMS profile 79939

5444 S Green St, Murray, UT 84123

Open in the dashboard

General payments

$80,398

199 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$13,220 paid to institutions, not to them · program year 2019

Through program year 2025, Aaron Bress of Murray, UT is reported in the CMS Open Payments database as having received $80,398 across 199 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $13,220 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,112 46
2024 General $33,797 57
2023 General $17,011 42
2022 General $11,463 36
2021 General $1,237 10
2019 General $1,779 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aaron Bress
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Aaron Bress were reported at $15,112. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Aaron Bress Diagnostic Radiology median Middle half National median
2019 $1,779 $108 $29–$318 $163
2020 $0 $65 $21–$252 $114
2021 $1,237 $92 $24–$292 $132
2022 $11,463 $104 $29–$294 $149
2023 $17,011 $110 $29–$337 $160
2024 $33,797 $113 $30–$356 $164
2025 $15,112 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $52,881 123 payments
  2. Penumbra, Inc. $18,906 49 payments
  3. Medtronic, Inc. $4,765 8 payments
  4. Medtronic USA, Inc. $1,701 5 payments
  5. Balt USA, LLC $966 6 payments
  6. Ge Healthcare $839 1 payment
  7. DePuy Synthes Sales Inc. $315 6 payments
  8. Medical Device Business Services, Inc. $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $51,419 14 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,334 6 payments
  3. Travel and Lodging $6,569 22 payments
  4. Food and Beverage $6,076 157 payments
Products named General payments · program years 2019–2025
  1. SURPASS EVOLVE $31,084 75 payments
  2. SYNCHRO SELECT $21,599 5 payments
  3. TARGET $17,081 22 payments
  4. TREVO $16,636 4 payments
  5. INFINITY $15,060 2 payments
  6. Penumbra System $11,607 25 payments
  7. AXS CATALYST 7 $10,219 5 payments
  8. AXS VECTA 71 $9,382 4 payments
  9. FLOWGATE2 $8,300 2 payments
  10. Smart Coil $6,463 7 payments
  11. Other $20,058 70 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$75,857

Medicare's payments for the services billed

Medicare patients

640

Average age 73

Services billed

1,065

354 women, 286 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Chronic kidney disease 37%
Depression 37%
Diabetes 35%
Ischemic heart disease 32%
Heart failure 24%
Atrial fibrillation 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

199 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record